George Abercrombie

George Abercrombie

Director/Board Member bei BIOCRYST PHARMACEUTICALS, INC.

Vermögen: 150 424 $ am 31.03.2024

69 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

George B.
Abercrombie
is currently an Independent Director at BioCryst Pharmaceuticals, Inc. and a Director at Physicians Interactive Holdings LLC.
He is also a Director at the North Carolina Glaxosmithkline Foundation, Hessian Pharmaceuticals, Inc., and the North Carolina Board of Science & Technology.
Additionally, he serves as an Adjunct Professor at The Fuqua School of Business.
In his former positions, Abercrombie served as the President & CEO-Pharmaceuticals Operations at Roche Holding AG.
He was also the President & Chief Executive Officer at Hoffmann-La Roche, Inc. from 2001 to 2009.
Abercrombie held the position of President & Chief Executive Officer at Roche Laboratories, Inc. and Vice Chairman at Project HOPE-The-People-To-People Health Foundation, Inc. He has also served as a Director at Vical, Inc., Inspire Pharmaceuticals, Inc., DemeRx, Inc., Brickell Subsidiary, Inc., OCERA Therapeutics LLC, Alaunos Therapeutics, Inc., Pharmaceutical Research & Manufacturers of America, Aptus Health, Inc., Tranzyme Pharma, Inc. (Canada), Johns Hopkins Bloomberg School of Public Health, Fresh Tracks Therapeutics, Inc., and Merck & Co., Inc. Abercrombie was the Chief Commercial Officer & Senior Vice President at Innoviva, Inc. from 2014 to 2018 and the Senior Vice President-US Commercial Operations at Glaxo Wellcome, Inc. from 1993 to 2001.
Abercrombie holds an MBA from Harvard University and an undergraduate degree from The University of North Carolina at Chapel Hill.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
13.06.2023 29 611 ( 0,01% ) 150 424 $ 31.03.2024

Aktive Positionen von George Abercrombie

UnternehmenPositionBeginn
BIOCRYST PHARMACEUTICALS, INC. Director/Board Member 24.05.2017
North Carolina Board of Science & Technology Corporate Officer/Principal -
Hessian Pharmaceuticals, Inc. Director/Board Member -
North Carolina Glaxosmithkline Foundation Director/Board Member -
Director/Board Member 24.09.2013
The Fuqua School of Business Corporate Officer/Principal -
Alle aktiven Positionen von George Abercrombie

Ehemalige bekannte Positionen von George Abercrombie

UnternehmenPositionEnde
FRESH TRACKS THERAPEUTICS, INC. Director/Board Member 27.05.2020
INNOVIVA, INC. Corporate Officer/Principal 26.09.2018
OCERA THERAPEUTICS INC Director/Board Member 11.11.2013
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von George Abercrombie im Detail an

Ausbildung von George Abercrombie

Harvard University Masters Business Admin
The University of North Carolina at Chapel Hill Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von George Abercrombie im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

26

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen6
BIOCRYST PHARMACEUTICALS, INC.

Health Technology

MERCK & CO., INC.

Health Technology

ROCHE HOLDING AG

Health Technology

INNOVIVA, INC.

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

FRESH TRACKS THERAPEUTICS, INC.

Health Technology

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Distribution Services

Glaxo Wellcome, Inc.

Health Technology

Commercial Services

Tranzyme Pharma, Inc. (Canada)

North Carolina Board of Science & Technology

Commercial Services

North Carolina Glaxosmithkline Foundation

Hessian Pharmaceuticals, Inc.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. George Abercrombie